|
Relationship Between rs1800896 and rs1465618 Polymorphisms in Prostate Adenocarcinoma in the Iranian Population
|
Golnoosh Tolue1    , Seyed Abdolhamid Angaji * 2, Behnaz Beikzadeh3 , Hengameh Alibeik4 , Raheleh Roudi5 , Behzad Narouie6 |
1- M.Sc Student of Genetics, Department of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran.
2- Associated Professor, Department of Cell and Molecular Biology, School of Biological Sciences, Kharazmi University, Tehran, Iran. , angaji@khu.ac.ir
3- Ph.D Candidate in Molecular Genetics, Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
4- Assistant Professor, Department of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, Iran.
5- Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA 94305, USA.
6- Urologist, Department of Urology, Zahedan University of Medical Sciences, Zahedan, Iran. |
|
|
Abstract: (1148 Views) |
Background and Objective: Prostate cancer is a malignancy affecting men. Identifying risk factors for prostate cancer is crucial for the potential development of interventions and expanding our biological understanding of this disease. The present study investigated the association of rs1800896 and rs1800896 with prostate adenocarcinoma.
Methods: This case-control study was conducted on 176 men, including 78 patients with prostate adenocarcinoma (case group) and 98 men with benign prostatic hyperplasia (control group), who visited the Labafinejad Educational and Treatment Center in Tehran, Iran. Genotyping was performed using the Tetra ARMS-PCR (amplification refractory mutation system-polymerase chain reaction) method.
Results: There was no statistically significant difference between the case and control groups in the genotype frequency of rs1800896 and rs1465618. However, the rs1800896 polymorphism was associated with PSA levels less than or equal to 4 ng/mL (P<0.05). Significant associations were found between rs1800896 and rs1465618 polymorphisms and clinical features, such as perineural invasion (P<0.05).
Conclusion: The rs1800896 and rs1465618 polymorphisms were not associated with the risk of prostate adenocarcinoma.
|
|
Keywords: Prostate [MeSH], Adenocarcinoma [MeSH], Interleukin-10 [MeSH], Single Nucleotide Polymorphisms (SNP) [MeSH], Iran [MeSH]
Article ID: Vol25-32 |
|
|
Full-Text [PDF 609 kb]
(2101 Downloads)
|
|
Type of Study: Original Articles |
Subject:
Genetic
|
|
|
|
|
|
|
| References |
1. Aaron L, Franco OE, Hayward SW. Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia. Urol Clin North Am. 2016 Aug; 43(3): 279-88. doi: 10.1016/j.ucl.2016.04.012. [ DOI] [ PubMed] 2. Hassanipour S, Fathalipour M, Salehiniya H. The incidence of prostate cancer in Iran: a systematic review and meta-analysis. Prostate Int. 2018 Jun; 6(2): 41-45. doi: 10.1016/j.prnil.2017.11.003. [ DOI] [ PubMed] 3. Luo X, Hu J, Gao X, Fan Y, Sun Y, Gu X, et al. Novel PYGL mutations in Chinese children leading to glycogen storage disease type VI: two case reports. BMC Med Genet. 2020 Apr; 21(1): 74. doi: 10.1186/s12881-020-01010-4. [ DOI] [ PubMed] 4. Henry GH, Malewska A, Joseph DB, Malladi VS, Lee J, Torrealba J, et al. A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra. Cell Rep. 2018 Dec; 25(12): 3530-42.e5. doi: 10.1016/j.celrep.2018.11.086. [ DOI] [ PubMed] 5. Tian JY, Guo FJ, Zheng GY, Ahmad A. Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities. Carcinogenesis. 2018 Mar; 39(3): 307-17. doi: 10.1093/carcin/bgx141. [ DOI] [ PubMed] 6. Bernal-Soriano MC, Parker LA, López-Garrigos M, Hernández-Aguado I, Caballero-Romeu JP, Gómez-Pérez L, et al. Factors associated with false negative and false positive results of prostate-specific antigen (PSA) and the impact on patient health: Cohort study protocol. Medicine (Baltimore). 2019 Oct; 98(40): e17451. doi: 10.1097/MD.0000000000017451. [ DOI] [ PubMed] 7. Catalona WJ, Partin AW, Sanda MG, Wei JT, Klee GG, Bangma CH, et al. A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. J Urol. 2011 May; 185(5): 1650-55. doi: 10.1016/j.juro.2010.12.032. [ DOI] [ PubMed] 8. Zhang S, Tang W, Ding G, Liu C, Liu R, Chen S, et al. Variant TP53BP1 rs560191 G>C is associated with risk of gastric cardia adenocarcinoma in a Chinese Han population. Chin J Cancer Res. 2015 Apr; 27(2): 156-62. doi: 10.3978/j.issn.1000-9604.2015.03.05. [ DOI] [ PubMed] 9. Mocellin S, Marincola F, Rossi CR, Nitti D, Lise M. The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev. 2004 Feb; 15(1): 61-76. doi: 10.1016/j.cytogfr.2003.11.001. [ DOI] [ PubMed] 10. Chen H, Tang J, Shen N, Ren K. Interleukin 10 gene rs1800896 polymorphism is associated with the risk of prostate cancer. Oncotarget. 2017 Aug; 8(39): 66204-14. doi: 10.18632/oncotarget.19857. [ DOI] [ PubMed] 11. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017 May; 67(3): 177-93. doi: 10.3322/caac.21395. [ DOI] [ PubMed] 12. Kingo K, Rätsep R, Kõks S, Karelson M, Silm H, Vasar E. Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. J Dermatol Sci. 2005 Feb; 37(2): 111-13. doi: 10.1016/j.jdermsci.2004.10.002. [ DOI] [ PubMed] 13. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010 Dec; 127(12): 2893-917. doi: 10.1002/ijc.25516. [ DOI] [ PubMed] 14. Zou YF, Wang F, Feng XL, Tian YH, Tao JH, Pan FM, et al. Lack of association of IL-10 gene polymorphisms with prostate cancer: evidence from 11,581 subjects. Eur J Cancer. 2011 May; 47(7): 1072-79. doi: 10.1016/j.ejca.2010.11.034. [ DOI] [ PubMed] 15. Yu D, Cheng M, Guo L, Liu W, Liu Y, Ning K, et al. Influence of oral nutritional agents rich in soluble dietary fiber on intestinal flora of elderly men with malnutrition. Aging Med (Milton). 2021 Aug; 4(3): 162-68. doi: 10.1002/agm2.12174. [ DOI] [ PubMed] 16. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010 Aug; 19(8): 1893-907. doi: 10.1158/1055-9965.EPI-10-0437. [ DOI] [ PubMed] 17. Mannino MH, Zhu Z, Xiao H, Bai Q, Wakefield MR, Fang Y. The paradoxical role of IL-10 in immunity and cancer. Cancer Lett. 2015 Oct; 367(2): 103-107. doi: 10.1016/j.canlet.2015.07.009. [ DOI] [ PubMed] 18. Yang Y, Fa X. Role of IL-10 gene polymorphisms on the susceptibility for esophageal cancer and its association with environmental factors. Int J Clin Exp Pathol. 2015 Aug; 8(8): 9580-85. [ PubMed] 19. Shao N, Xu B, Mi YY, Hua LX. IL-10 polymorphisms and prostate cancer risk: a meta-analysis. Prostate Cancer Prostatic Dis. 2011 Jun; 14(2): 129-35. doi: 10.1038/pcan.2011.6. [ DOI] [ PubMed] 20. Ruan XL, Li S, He ZQ, Huang JY, Zhang C, Weng H. Meta-analysis on the possible role of interluekin-10 rs1800896 polymorphism in association with prostate cancer susceptibility. Int J Clin Exp Med. 2017; 10(2): 1967-75. [ View at Publisher] |
|
| Send email to the article author |
|
|
|
Tolue G, Angaji S A, Beikzadeh B, Alibeik H, Roudi R, Narouie B. Relationship Between rs1800896 and rs1465618 Polymorphisms in Prostate Adenocarcinoma in the Iranian Population. J Gorgan Univ Med Sci 2023; 25 (3) :43-49 URL: http://goums.ac.ir/journal/article-1-4256-en.html
|
